Contrast agents for MR imaging of the liver

被引:32
作者
Low, RN
机构
[1] Sharp and Children's MRI Center, SHARP HealthCare, San Diego, CA 92123
来源
JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING | 1997年 / 7卷 / 01期
关键词
MR imaging; liver; MR; contrast agents; liver neoplasms; gadolinium; manganese; iron;
D O I
10.1002/jmri.1880070109
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The evolution of contrast agents for MR imaging of the liver has proceeded along several different paths with the common goal of improving liver-lesion contrast. These contrast agents are used to accentuate the inherent differences in liver-lesion signal intensity through differential enhancement of proton relaxation within adjacent tissues. Contrast agents used for hepatic MR imaging can be broadly categorized into those that target the extracellular space, the hepatobiliary system, and the reticuloendothelial system. Although only a small number of liver contrast agents are currently available, others are rapidly proceeding through clinical trials and may soon be added to our clinical armamentarium. This article will briefly review the current clinical experience with these agents, discussing their mechanism of contrast enhancement, pharmacokinetics, and efficacy in the evaluation of focal liver lesions.
引用
收藏
页码:56 / 67
页数:12
相关论文
共 76 条
[1]   MN-DPDP - ENHANCED MR-IMAGING OF MALIGNANT LIVER-LESIONS - EFFICACY AND SAFETY IN 20 PATIENTS [J].
AICHER, KP ;
LANIADO, M ;
KOPP, AF ;
GRONEWALLER, E ;
DUDA, SH ;
CLAUSSEN, CD .
JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1993, 3 (05) :731-737
[2]  
BARON RL, 1995, RADIOLOGY, V197, P415
[3]   LIVER METASTASES - SAFETY AND EFFICACY OF DETECTION WITH SUPERPARAMAGNETIC IRON-OXIDE IN MR-IMAGING [J].
BELLIN, MF ;
ZAIM, S ;
AUBERTON, E ;
SARFATI, G ;
DURON, JJ ;
KHAYAT, D ;
GRELLET, J .
RADIOLOGY, 1994, 193 (03) :657-663
[4]   HEPATIC MR IMAGING WITH MN-DPDP - SAFETY, IMAGE QUALITY, AND SENSITIVITY [J].
BERNARDINO, ME ;
YOUNG, SW ;
LEE, JKT ;
WEINREB, JC .
RADIOLOGY, 1992, 183 (01) :53-58
[5]   COMPARISON OF CONTRAST-ENHANCED CT AND MN-DPDP ENHANCED MRI FOR DETECTION OF FOCAL HEPATIC-LESIONS INITIAL FINDINGS [J].
BIRNBAUM, BA ;
WEINREB, TC ;
FERNANDEZ, MP ;
BROWN, JJ ;
ROFSKY, NM ;
YOUNG, SW .
CLINICAL IMAGING, 1994, 18 (01) :21-27
[6]  
BOURNE M, 1993, 8 EUR C RAD, P125
[7]   Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA) - Preliminary results of phase II clinical application [J].
Caudana, R ;
Morana, G ;
Pirovano, GP ;
Nicoli, N ;
Portuese, A ;
Spinazzi, A ;
DiRito, R ;
Pistolesi, GF .
RADIOLOGY, 1996, 199 (02) :513-520
[8]   LIVER AND ABDOMINAL SCREENING IN PATIENTS WITH CANCER - CT VERSUS MR IMAGING [J].
CHEZMAR, JL ;
RUMANCIK, WM ;
MEGIBOW, AJ ;
HULNICK, DH ;
NELSON, RC ;
BERNARDINO, ME .
RADIOLOGY, 1988, 168 (01) :43-47
[9]   SOLUBLE-TYPE HEPATOBILIARY CONTRAST AGENTS FOR MR IMAGING [J].
DEHAEN, C ;
GOZZINI, L .
JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1993, 3 (01) :179-186
[10]   HEPATIC TUMORS - DETECTION AND CHARACTERIZATION AT 1-T MR-IMAGING ENHANCED WITH AMI-25 [J].
DENYS, A ;
ARRIVE, L ;
SERVOIS, V ;
DUBRAY, B ;
NAJMARK, D ;
SIBERT, A ;
MENU, Y .
RADIOLOGY, 1994, 193 (03) :665-669